JAK2 and acute lymphoblastic leukemia: These results raised the possibility that the modest effects of type I JAK2is in JAK2 mutant B-ALL may not be due to paradoxical JAK2Y1007/1008 hyperphosphorylation but rather may be due to the cells not being primarily reliant on mutant JAK2 for sustained survival and/or proliferation.